WEDGE(SZ:000534) Sou Hu Cai Jing·2025-08-11 12:49Group 1 - The core viewpoint of the news is that Wanzhe Co., Ltd. has shown a positive performance in its latest quarterly report, with significant revenue and profit growth [1] - As of August 11, 2025, Wanzhe Co., Ltd. reported a closing price of 17.1 yuan, a decrease of 0.87%, with a turnover rate of 9.17% and a trading volume of 456,700 hands, amounting to 779 million yuan [1] - The company's latest quarterly report indicates total operating revenue of 335 million yuan, a year-on-year increase of 15.34%, and a net profit attributable to shareholders of 72.69 million yuan, up 10.52% year-on-year [1] Group 2 - The company has a current ratio of 1.368, a quick ratio of 0.953, and a debt-to-asset ratio of 58.89% [1] - Wanzhe Co., Ltd. was established in 1992 and is primarily engaged in the pharmaceutical manufacturing industry, with a registered capital of 500.71 million yuan [1] - The company has made investments in 14 enterprises and has participated in one bidding project, along with holding four administrative licenses [2]